
TY  - JOUR
AU  - Carvalho, YR
AU  - Loyola, AM
AU  - Gomez, RS
AU  - Araújo, VC
TI  - Peripheral giant cell granuloma. An immunohistochemical and ultrastructural study
JO  - Oral Diseases
VL  - 1
IS  - 1
SN  - 1354-523X
UR  - https://doi.org/10.1111/j.1601-0825.1995.tb00152.x
DO  - doi:10.1111/j.1601-0825.1995.tb00152.x
SP  - 20
EP  - 25
KW  - peripheral giant cell granuloma
KW  - immunocytochem-istry
KW  - ultrastructure
PY  - 1995
AB  - OBJECTIVE: To study the nature of multinucleated and mononuclear cells from peripheral giant cell granuloma (PGCG). MATERIALS AND METHODS: Formalin-fixed, paraffin-embedded sections of 40 cases of PGCG were immunohistochemically stained for vimentin, alpha I-antichymotrypsin, CD68, S-100 protein, lysozyme. leucocyte common antigen (LCA), factor VIII-retated antigen and muscle cell actin. Six cases of PGCG were also studied by transmission etectron microscopy. RESULTS: Vimentin, alpha I-antichymotrypsin and CD68 were expressed in both the mononuclear and multinucleated giant cells. Dendritic mononuclear cells, positive for 5?100 protein, were noted in 67.5% of the lesions, whereas lysozyme and leucocyte common antigen were detected in occasional mononuclear cells. Ultrastructural examination showed mononuclear cells with signs of phagocytosis and sometimes interdigitations with similar cells. Others presented non-specific characteristics and the third type exhibited cytoplasmic processes and occasional Birbeck granules. Some multi-nucleated giant cells showed oval nuclei, abundant mitochondria and granular endoplasmic reticulum whereas others presented with irregular nuclei and a great number of cytoplasmic vacuoles. CONCLUSIONS: lmmunohistochemical and ultrastructural results suggest that PGCGs of the jaws are composed mainly of cells of the mononuclear phagocyte system and that Langerhans cells are present in two thirds of the lesions.
ER  - 

TY  - JOUR
AU  - Devine, D. V.
AU  - Reesink, H. W.
AU  - Panzer, S.
AU  - Irving, D. O.
AU  - Körmöczi, G. F.
AU  - Mayr, W. R.
AU  - Blais, Y.
AU  - Zhu, Y.
AU  - Qian, K.
AU  - Zhu, Z.
AU  - Greinacher, A.
AU  - Grazzini, G.
AU  - Pupella, S.
AU  - Catalano, L.
AU  - Vaglio, S.
AU  - Liumbruno, G. M.
AU  - Smeenk, J. W.
AU  - Josemans, E. A. J.
AU  - Briët, E.
AU  - Letowska, M.
AU  - Lachert, E.
AU  - Antoniewicz-Papis, J.
AU  - Brojer, E.
AU  - Gulliksson, H.
AU  - Scott, M.
AU  - Williamson, L
AU  - Prowse, C.
AU  - AuBuchon, J. P.
AU  - López, J. A.
AU  - Hoffman, P.
AU  - Busch, M. P.
AU  - Norris, P. J.
AU  - Tomasulo, P.
AU  - Dodd, R. Y.
TI  - Research and development
JO  - Vox Sanguinis
VL  - 99
IS  - 4
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2010.01379.x
DO  - doi:10.1111/j.1423-0410.2010.01379.x
SP  - 382
EP  - 401
PY  - 2010
ER  - 

TY  - JOUR
TI  - Monday 21st November
JO  - Clinical & Experimental Ophthalmology
VL  - 39
IS  - s1
SN  - 1442-6404
UR  - https://doi.org/10.1111/j.1442-9071.2011.02690.x
DO  - doi:10.1111/j.1442-9071.2011.02690.x
SP  - 23
EP  - 41
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 176
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.14613
DO  - doi:10.1111/bjh.14613
SP  - 5
EP  - 145
PY  - 2017
ER  - 

TY  - JOUR
AU  - Richterman, A.
AU  - Sawinski, D.
AU  - Reese, P. P.
AU  - Lee, D. H.
AU  - Clauss, H.
AU  - Hasz, R. D.
AU  - Thomasson, A.
AU  - Goldberg, D. S.
AU  - Abt, P. L.
AU  - Forde, K. A.
AU  - Bloom, R. D.
AU  - Doll, S. L.
AU  - Brady, K. A.
AU  - Blumberg, E. A.
TI  - An Assessment of HIV-Infected Patients Dying in Care for Deceased Organ Donation in a United States Urban Center
JO  - American Journal of Transplantation
VL  - 15
IS  - 8
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.13308
DO  - doi:10.1111/ajt.13308
SP  - 2105
EP  - 2116
KW  - Acquired immunodeficiency syndrome
KW  - donors and donation: deceased
KW  - donors and donation: donor-derived infections
KW  - donors and donation: extended criteria
KW  - infection and infectious agents
KW  - viral: human immunodeficiency virus
PY  - 2015
AB  - Organ transplantation is an acceptable option for human immunodeficiency virus (HIV)-infected patients with end-stage kidney or liver disease. With worse outcomes on the waitlist, HIV-infected patients may actually be disproportionately affected by the organ shortage in the United States. One potential solution is the use of HIV-infected deceased donors (HIVDD), recently legalized by the HIV Organ Policy Equity (HOPE) Act. This is the first analysis of patient-specific data from potential HIVDD, retrospectively examining charts of HIV-infected patients dying in care at six HIV clinics in Philadelphia, Pennsylvania from January 1, 2009 to June 30, 2014. Our data suggest that there are four to five potential HIVDD dying in Philadelphia annually who might yield two to three kidneys and three to five livers for transplant. Extrapolated nationally, this would approximate 356 potential HIVDD yielding 192 kidneys and 247 livers annually. However, several donor risk indices raise concerns about the quality of kidneys that could be recovered from HIVDD as a result of older donor age and comorbidities. On the other hand, livers from these potential HIVDD are of similar quality to HIV-negative donors dying locally, although there is a high prevalence of positive hepatitis C antibody.
ER  - 

TY  - JOUR
TI  - Poster Session TPS 34-48
JO  - Allergy
JA  - Allergy
VL  - 71
IS  - S102
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12978
DO  - doi:10.1111/all.12978
SP  - 528
EP  - 591
PY  - 2016
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology, SIOP XXXVII Annual Congress Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 45
IS  - 4
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.20588
DO  - doi:10.1002/pbc.20588
SP  - 365
EP  - 608
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts of the Hemostasis & Thrombosis Research Society, 2011 Annual Scientific Symposium, April 28-30, Northwestern Memorial Hospital, Chicago, IL
JO  - Haemophilia
VL  - 17
IS  - 3
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2011.02551.x
DO  - doi:10.1111/j.1365-2516.2011.02551.x
SP  - 564
EP  - 569
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJU International
JA  - BJU Int
VL  - 111
IS  - S1
SN  - 1464-4096
UR  - https://doi.org/10.1111/bju.12069
DO  - doi:10.1111/bju.12069
SP  - 13
EP  - 119
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 11
IS  - s2
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2005.clm_1134_01.x
DO  - doi:10.1111/j.1469-0691.2005.clm_1134_01.x
SP  - 99
EP  - 237
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Abstract
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 48
IS  - S1
SN  - 0014-2972
UR  - https://doi.org/10.1111/eci.12926
DO  - doi:10.1111/eci.12926
SP  - 70
EP  - 225
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 13 September
JO  - European Journal of Neurology
VL  - 16
IS  - s3
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2009.02821.x
DO  - doi:10.1111/j.1468-1331.2009.02821.x
SP  - 55
EP  - 334
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 119
IS  - S2
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.12659
DO  - doi:10.1111/bcpt.12659
SP  - 3
EP  - 37
PY  - 2016
ER  - 

TY  - JOUR
TI  - Sunday 23rd November
JO  - Clinical & Experimental Ophthalmology
JA  - Clin Experiment Ophthalmol
VL  - 42
IS  - S1
SN  - 1442-6404
UR  - https://doi.org/10.1111/ceo.12446
DO  - doi:10.1111/ceo.12446
SP  - 8
EP  - 24
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Clinical & Experimental Ophthalmology
JA  - Clin Experiment Ophthalmol
VL  - 40
IS  - S1
SN  - 1442-6404
UR  - https://doi.org/10.1111/ceo.12009
DO  - doi:10.1111/ceo.12009
SP  - 63
EP  - 118
PY  - 2012
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 107
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12153
DO  - doi:10.1111/vox.12153
SP  - 1
EP  - 56
PY  - 2014
ER  - 

TY  - JOUR
TI  - Tuesday, December 4, 2007 Subcortical Control of Cortical Excitability 11:00 a.m.-12:30 p.m.
JO  - Epilepsia
VL  - 48
IS  - s6
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2007.01252_14.x
DO  - doi:10.1111/j.1528-1167.2007.01252_14.x
SP  - 410
EP  - 410
PY  - 2007
AB  - Robert S. Fisher 1 , Lucy Brown 2 and Karen Gale 3 ( 1 Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA ; 2 Albert Einstein College of Medicine, Yeshiva University, Bronx, NY and 3 Neurology and Neuroscience, Georgetown University School of Medicine, Washington, D.C., WA ) Summary: This symposium will evaluate the role of certain subcortical circuits in seizures and cortical excitability. Data show that thalamocortical, basal ganglia, midbrain and hindbrain circuits play important roles in seizure generation, conduction and modulation. The session will provide a basic overview of these systems and circuits, both functionally and anatomically. The thalamus uses systems able to synchronize or desynchronize electrical activity in wide regions of cortex. These thalamocortical systems play a role in generation of absence seizures and propagation of secondarily generalized seizures. The basal ganglia have a close relationship with the cortex, and may ?gate? activity through a widespread corticostriate system, thus potentially both enhancing and suppressing seizure activity. Midbrain and hindbrain circuits have been shown to have profound effects on seizures. The session will discuss how an understanding of subcortical-cortical networks can lead to therapeutic advances, with use of electrical brain stimulation or targeted pharmacotherapy as examples.
ER  - 

TY  - JOUR
TI  - Monday, December 3, 2007 Strategic Approaches to Pediatric Epilepsy Surgery 7:00 p.m.-9:00 p.m.
JO  - Epilepsia
VL  - 48
IS  - s6
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2007.01252_12.x
DO  - doi:10.1111/j.1528-1167.2007.01252_12.x
SP  - 410
EP  - 410
PY  - 2007
AB  - Elaine Wyllie 1 and Michael Duchowny 2 ( 1 Cleveland Clinic Foundation, Cleveland, OH and 2 Brain Institute, Miami Children's Hospital, Miami, FL ) Summary: Epilepsy surgery is accepted as an appropriate intervention for children with medically refractory epilepsy. Key elements for surgical candidacy include a localized epileptogenic zone and a low risk for new postoperative neurological deficits. The strategies for identifying these elements for surgical candidacy are in evolution. This Symposium will examine current worldwide variations in pediatric epilepsy surgical practice, based on an international multicenter survey. Faculty will also examine age-related aspects to selection for surgery including lesion timing and type and functional plasticity, and strategies for surgery when MRI is normal or shows multiple lesions. Pediatric neurology and neurosurgery speakers will emphasize the tactics involved in designing a safe and effective plan for surgery for selected infants and children with intractable epilepsy.
ER  - 

TY  - JOUR
TI  - Third European Congress of Oral Medicine
JO  - Oral Diseases
VL  - 3
IS  - 1
SN  - 1354-523X
UR  - https://doi.org/10.1111/j.1601-0825.1997.tb00008.x
DO  - doi:10.1111/j.1601-0825.1997.tb00008.x
SP  - 43
EP  - 48
PY  - 1997
ER  - 

TY  - JOUR
TI  - Abstracts of the IPITA-IXA-CTS 2015 Joint Congress November 15–19, 2015, Melbourne, Australia
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 22
IS  - S1
SN  - 0908-665X
UR  - https://doi.org/10.1111/xen.12204
DO  - doi:10.1111/xen.12204
SP  - S2
EP  - S47
PY  - 2015
ER  - 
